GYRE THERAPEUTICS, INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

GYRE THERAPEUTICS, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $116.59 million for the year ending 2025.

  • GYRE THERAPEUTICS, INC. showed an increase of +10.2% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from GYRE THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2017 to 2025), GYRE THERAPEUTICS, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 11,352.7%.
  • Historical annual values: Fiscal year 2025: $116.59 million | Fiscal year 2024: $105.76 million | Fiscal year 2023: $113.45 million | Fiscal year 2022: $102.29 million | Fiscal year 2021: $7.34 million | Fiscal year 2020: $20.95 million | Fiscal year 2018: $6.0 thousand | Fiscal year 2017: $1.02 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: